Reliant licenses Abbott's Rythmol line
Executive Summary
Reliant Pharmaceuticals (sells ethical pharmaceuticals in primary care and specialty markets) paid $93mm for the exclusive US rights to market, sell, and distribute Abbott Laboratories' Rythmol (propafenone HCl) anti-arrhythmic product line.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Marketing (Licensing)
- Reverse Licensing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice